00:00 Speaker A
Now time for some of today’s training tickers sponsored by Tasty Trade. We’re checking in on shares of TransMedics, Rocket Lab and Toast. Let’s start with TransMedics, uh, medical equipment company topping earnings estimates, um, in its most latest quarter, and it also raised its revenue guidance for the full year. Uh, the company beating on the top and bottom line here, total revenue coming in at $143 and a half million dollars here. Um, and the company seeing some success, um, in one of its liver products in particular, but overall, uh, doing well here.
00:48 Speaker B
Yeah, it looks like, uh, most on the street still like this one. Uh, the move on the stock so far this year is tremendous. It’s up around 80%. Uh, Piper look like to me raised the target to 125. They maintain the overweight. William Blair also likes it. They have an outperform, told their clients they view the results as strong, should help offset some of the debate regarding the company’s market position. They say an increasingly competitive environment, they view the company say as one of the better organic growth stories in our coverage universe.
01:32 Speaker A
Interesting. As you say, um, up about 80% this year.
01:37 Speaker B
Yep. Our shares of Rocket Lab tumbling today after posting a wider than expected loss for the first quarter. Company also issued revenue guidance for the second quarter that missed on the lower side. Uh, so for Q1, looks like revenue beats. Adjust EBITDA loss, 30 million. estimate was 34 million. Uh the in terms of looking ahead, they forecast revenue for second quarter 130 to 140 per Bloomberg. The estimate was 136.8. They see an adjusted EBITDA loss of 28 to 30. The estimate was was a loss of 21.4 million. Also saying it intends to establish a holding company structure, a new parent company Rocket Lab Corporation.
02:55 Speaker A
Right.
02:56 Speaker B
Yeah, it looks like that forecast EBITDA loss in particular, um, hitting the stock here. But on the call, they also talked about developing their new, uh, their own rocket to try to place some of their satellites in space. So that’s sort of an ongoing effort on the part of Rocket Lab. But this has been one that, um, sort of retail investors have looked to to help them play this industry because there aren’t a lot of publicly traded ways to play space so to speak. Um, you know, we were just talking about our first trender, which is up 80% this year. This one is down about 19% year to date. So, they haven’t seen that bear fruit. But over the past year,
03:56 Speaker B
huge.
03:58 Speaker A
huge gains.
04:00 Speaker B
Huge, nearly 400%. Yep. Exactly.
04:04 Speaker A
Yeah.
04:05 Speaker B
And despite that, I mean, despite 400%, still mostly fans on the street. Does look like Canter takes their target to 29, maintains the overweight.
04:18 Speaker A
Gotcha. And then let’s talk about Toast. Those shares popping today on the back of a guidance boost. The company raising its adjusted EBITDA guidance for the full year topping estimates. Now, Toast, um, provides both hardware and software, um, to restaurants and other types of businesses here. So also kind of a good read on what’s going on in the economy. They actually raised their forecast for EBITDA for the full year, um, as well as for, um, well, their second quarter forecast for beating estimates here, subscription revenue coming in, um, last quarter, the first quarter, a little bit higher than estimated.
05:12 Speaker B
Yeah, street is fairly divided on this one. Stock nice runs up about 12% this year, more than 50% over the past 12 months. Uh, just looking at some analyst notes, Evercore, which has the equivalent of a hold here. Stock reaction, they say likely due to a mix of offsetting data points, like weaker new location adds, balanced with promising ARR growth and the announcement of another large enterprise win that would be Topgolf.